Table 3.
Characteristics of exposure to varicella-zoster virus in 104 pregnant women treated with VZIG from December 2005 to March 2015
| % (n) | ||
|---|---|---|
| Source of exposure | Own child | 57·7 (60) |
| Other known child | 20·2 (21) | |
| Staff in daycare institution | 6·7 (7) | |
| Adult friend or relative | 5·8 (6) | |
| Another child in a daycare institution | 3·9 (4) | |
| Missing | 5·8 (6) | |
| Time from exposure to VZIG administration | 0–2 days | 34·6 (36) |
| 3–4 days | 22·1 (23) | |
| 5–9 days | 38·5 (40) | |
| >10 days | 4·8 (5) | |
| Missing | 0 |
VZIG, Varicella-zoster immunoglobulin.
Missing values are due to missing information from the VZIG formula or from the questionnaire.